Corporate Briefing Note
171026-T-PAA-Corporate Briefing Note-AG
171010_PharmAust secures broad patent in US for non-cancer applications of Monepantel
171003_Two key appointments to bolster PharmAust veterinary drug programs
171026_Appendix 4C – Quarterly Report and Company Update for the period ended 30 September 2017
170920_Reformulation project achieves first milestones and on- track
170912_PharmAust secures core Europe patent